# Option Care Health, Inc.: filings

OPCH · Nasdaq · CIK 1014739 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/opch.md) · [Financials](/companies/opch/financials.md) · [Filings](/companies/opch/filings.md) · [Insiders](/companies/opch/insiders.md)

## Reports and events: 426 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 554, 8-K 249, 3 75, SC 13D/A 61, SC 13G/A 58, 10-Q 53, DEFA14A 50, SC 13G 28, UPLOAD 21, 425 19, DEF 14A 19, 10-K 18, CORRESP 17, SC 13D 11, 144 9, 424B5 9, 4/A 9, EFFECT 9, 424B4 8, 5 8, S-8 8, S-3 7, 8-K/A 6, PRE 14A 6, 10-K/A 5, CT ORDER 5, SCHEDULE 13G/A 5, 10-Q/A 4, S-3/A 4, SCHEDULE 13G 4, 3/A 3, 424B3 3, ARS 3, S-4 3, D 2, DEFM14A 2, FWP 2, PREM14A 2, PRER14A 2, S-4/A 2, 424B7 1, 8-A12B 1, 8-A12G/A 1, DEF 14C 1, DEFR14A 1, NT 10-K 1, PRE 14C 1, RW 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 08:22 ET | [8-K](/filings/0001104659-26-113904.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-113904 |
| 2026-07-29 | 07:26 ET | [10-Q](/filings/0001014739-26-000023.md) | Quarterly report, period 2026-06-30 | 0001014739-26-000023 |
| 2026-07-29 | 06:56 ET | [8-K](/filings/0001014739-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-26-000021 |
| 2026-05-22 | 16:00 ET | [8-K](/filings/0001014739-26-000017.md) | 5.07 Shareholder vote results | 0001014739-26-000017 |
| 2026-05-12 | 07:00 ET | [8-K](/filings/0001104659-26-058979.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-058979 |
| 2026-05-05 | 16:01 ET | [8-K](/filings/0001014739-26-000014.md) | 5.02 Departure or appointment of officers or directors | 0001014739-26-000014 |
| 2026-04-30 | 16:00 ET | [10-Q](/filings/0001014739-26-000011.md) | Quarterly report, period 2026-03-31 | 0001014739-26-000011 |
| 2026-04-30 | 07:01 ET | [8-K](/filings/0001104659-26-052099.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-052099 |
| 2026-04-08 | 16:15 ET | [DEF 14A](/filings/0001140361-26-013825.md) | Proxy statement, period 2026-05-20 | 0001140361-26-013825 |
| 2026-04-02 | 16:15 ET | [8-K](/filings/0001104659-26-039171.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-039171 |
| 2026-02-24 | 16:02 ET | [10-K](/filings/0001014739-26-000008.md) | Annual report, period 2025-12-31 | 0001014739-26-000008 |
| 2026-02-24 | 06:55 ET | [8-K](/filings/0001014739-26-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-26-000005 |
| 2026-01-12 | 16:31 ET | [8-K](/filings/0001104659-26-002887.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002887 |
| 2025-10-30 | 16:02 ET | [10-Q](/filings/0001014739-25-000046.md) | Quarterly report, period 2025-09-30 | 0001014739-25-000046 |
| 2025-10-30 | 06:56 ET | [8-K](/filings/0001014739-25-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-25-000043 |
| 2025-09-25 | 16:05 ET | [8-K](/filings/0001104659-25-093337.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-093337 |
| 2025-08-20 | 16:07 ET | [8-K](/filings/0001104659-25-080912.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-080912 |
| 2025-07-30 | 16:01 ET | [10-Q](/filings/0001014739-25-000037.md) | Quarterly report, period 2025-06-30 | 0001014739-25-000037 |
| 2025-07-30 | 06:58 ET | [8-K](/filings/0001014739-25-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-25-000034 |
| 2025-05-16 | 16:00 ET | [8-K](/filings/0001014739-25-000028.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001014739-25-000028 |
| 2025-04-29 | 16:00 ET | [10-Q](/filings/0001014739-25-000022.md) | Quarterly report, period 2025-03-31 | 0001014739-25-000022 |
| 2025-04-29 | 06:57 ET | [8-K](/filings/0001014739-25-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-25-000018 |
| 2025-04-02 | 16:06 ET | [DEF 14A](/filings/0001140361-25-011852.md) | Proxy statement, period 2025-05-14 | 0001140361-25-011852 |
| 2025-02-26 | 16:01 ET | [10-K](/filings/0001014739-25-000012.md) | Annual report, period 2024-12-31 | 0001014739-25-000012 |
| 2025-02-26 | 06:56 ET | [8-K](/filings/0001014739-25-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-25-000008 |
| 2025-01-13 | 07:05 ET | [8-K](/filings/0001104659-25-002847.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-002847 |
| 2024-10-30 | 16:00 ET | [10-Q](/filings/0001014739-24-000052.md) | Quarterly report, period 2024-09-30 | 0001014739-24-000052 |
| 2024-10-30 | 06:58 ET | [8-K](/filings/0001014739-24-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-24-000048 |
| 2024-09-06 | 16:01 ET | [8-K](/filings/0001014739-24-000041.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws | 0001014739-24-000041 |
| 2024-07-31 | 16:00 ET | [10-Q](/filings/0001014739-24-000035.md) | Quarterly report, period 2024-06-30 | 0001014739-24-000035 |
| 2024-07-31 | 06:59 ET | [8-K](/filings/0001014739-24-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-24-000032 |
| 2024-05-17 | 16:01 ET | [8-K](/filings/0001014739-24-000025.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001014739-24-000025 |
| 2024-05-10 | 16:07 ET | [8-K](/filings/0001104659-24-059895.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-059895 |
| 2024-04-23 | 16:01 ET | [10-Q](/filings/0001014739-24-000022.md) | Quarterly report, period 2024-03-31 | 0001014739-24-000022 |
| 2024-04-23 | 06:59 ET | [8-K](/filings/0001014739-24-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-24-000019 |
| 2024-04-03 | 16:06 ET | [DEF 14A](/filings/0001140361-24-017579.md) | Proxy statement, period 2024-05-15 | 0001140361-24-017579 |
| 2024-03-14 | 16:00 ET | [8-K](/filings/0001014739-24-000013.md) | 7.01 Regulation FD disclosure | 0001014739-24-000013 |
| 2024-02-22 | 16:02 ET | [10-K](/filings/0001014739-24-000009.md) | Annual report, period 2023-12-31 | 0001014739-24-000009 |
| 2024-02-22 | 06:59 ET | [8-K](/filings/0001014739-24-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-24-000007 |
| 2023-12-29 | 16:00 ET | [8-K](/filings/0001104659-23-130458.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-130458 |
| 2023-12-11 | 17:00 ET | [8-K](/filings/0001104659-23-125031.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-23-125031 |
| 2023-10-25 | 16:02 ET | [10-Q](/filings/0001014739-23-000042.md) | Quarterly report, period 2023-09-30 | 0001014739-23-000042 |
| 2023-10-25 | 07:00 ET | [8-K](/filings/0001014739-23-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-23-000040 |
| 2023-07-27 | 16:00 ET | [10-Q](/filings/0001014739-23-000034.md) | Quarterly report, period 2023-06-30 | 0001014739-23-000034 |
| 2023-07-27 | 06:59 ET | [8-K](/filings/0001014739-23-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-23-000032 |
| 2023-06-26 | 09:02 ET | [8-K](/filings/0001104659-23-074575.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-074575 |
| 2023-06-21 | 07:00 ET | [8-K](/filings/0001104659-23-073117.md) | 8.01 Other events | 0001104659-23-073117 |
| 2023-06-12 | 17:02 ET | [SC 13D/A](/filings/0001193125-23-165408.md) | Ownership report, active investor, amended | 0001193125-23-165408 |
| 2023-05-19 | 16:04 ET | [8-K](/filings/0001014739-23-000022.md) | 5.07 Shareholder vote results | 0001014739-23-000022 |
| 2023-05-04 | 17:00 ET | [10-Q](/filings/0001014739-23-000019.md) | Quarterly report, period 2023-03-31 | 0001014739-23-000019 |

Page 1 of 9. [Older](/companies/opch/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:18 ET. No prices; not investment advice.